Volumetric breast density estimation from full-field digital mammograms

IEEE Transactions on Medical Imaging
Saskia van EngelandNico Karssemeijer

Abstract

A method is presented for estimation of dense breast tissue volume from mammograms obtained with full-field digital mammography (FFDM). The thickness of dense tissue mapping to a pixel is determined by using a physical model of image acquisition. This model is based on the assumption that the breast is composed of two types of tissue, fat and parenchyma. Effective linear attenuation coefficients of these tissues are derived from empirical data as a function of tube voltage (kVp), anode material, filtration, and compressed breast thickness. By employing these, tissue composition at a given pixel is computed after performing breast thickness compensation, using a reference value for fatty tissue determined by the maximum pixel value in the breast tissue projection. Validation has been performed using 22 FFDM cases acquired with a GE Senographe 2000D by comparing the volume estimates with volumes obtained by semi-automatic segmentation of breast magnetic resonance imaging (MRI) data. The correlation between MRI and mammography volumes was 0.94 on a per image basis and 0.97 on a per patient basis. Using the dense tissue volumes from MRI data as the gold standard, the average relative error of the volume estimates was 13.6%.

References

Feb 1, 1990·Physics in Medicine and Biology·C B CaldwellM J Yaffe
Jun 1, 1987·Physics in Medicine and Biology·P C Johns, M J Yaffe
Nov 1, 1995·Journal of the National Cancer Institute·C ByrneR Haile
Nov 1, 1996·Radiographics : a Review Publication of the Radiological Society of North America, Inc·U BickK Doi
May 1, 1997·Radiology·J W ByngM J Yaffe
Mar 24, 1998·Physics in Medicine and Biology·N Karssemeijer
Jun 12, 1998·Physics in Medicine and Biology·J W ByngM J Yaffe
Nov 20, 1998·Radiographics : a Review Publication of the Radiological Society of North America, Inc·J W ByngN F Boyd
Jan 22, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·C H van GilsA L Verbeek
Feb 29, 2000·Journal of Medical Screening·C H van GilsA L Verbeek
Jul 7, 2001·Medical Physics·C ZhouL M Hadjiiski
Aug 22, 2001·IEEE Transactions on Medical Imaging·P K SahaD Sullivan
Dec 20, 2002·AJR. American Journal of Roentgenology·Xiao Hui WangLara A Hardesty
Jul 15, 2004·IEEE Transactions on Medical Imaging·Peter R Snoeren, Nico Karssemeijer
Aug 13, 2004·Medical Physics·Arthur Burgess
Nov 17, 2004·European Journal of Radiology·Kostas MariasMichael Brady
Oct 1, 1994·Physics in Medicine and Biology·J W ByngM J Yaffe

❮ Previous
Next ❯

Citations

Apr 14, 2011·Aesthetic Plastic Surgery·Martin C KochAlexander Cavallaro
May 14, 2010·Physics in Medicine and Biology·O Alonzo-ProulxM J Yaffe
Jul 5, 2012·Journal of the National Cancer Institute·John J HeineCeline M Vachon
Jun 7, 2006·Medical Physics·John A ShepherdSteve R Cummings
May 21, 2013·Annual Review of Biomedical Engineering·Maryellen L GigerJulia A Schnabel
Jun 6, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Valerie A McCormackIsabel dos Santos Silva
Jul 17, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·John A ShepherdGertraud Maskarinec
Feb 10, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Zoe AitkenIsabel dos Santos Silva
May 26, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·John A ShepherdSteven R Cummings
Jan 15, 2008·Breast Cancer Research : BCR·Celine M VachonV Shane Pankratz
Jul 5, 2008·Breast Cancer Research : BCR·Martin J Yaffe
Dec 11, 2013·PloS One·Jeff WangJohn A Shepherd
Jan 28, 2014·PloS One·Albert Gubern-MéridaNico Karssemeijer
Apr 10, 2014·Breast Cancer Research : BCR·Mads NielsenMorten A Karsdal
Mar 3, 2011·Medical Physics·Woo Kyung MoonRuey-Feng Chang
Dec 10, 2009·Medical Physics·Jeon-Hor ChenRuey-Feng Chang
Oct 10, 2008·Medical Physics·Carri K Glide-HurstPeter Littrup
Jan 26, 2010·Medical Physics·M J YaffeK Brock
Apr 15, 2008·Medical Physics·Thomas R NelsonKaren K Lindfors
Apr 24, 2013·Radiology·Jennifer A HarveyEdward A Sickles
Jun 26, 2014·Radiological Physics and Technology·Martin J Yaffe
Feb 3, 2016·Ultrasound in Medicine & Biology·Jeon-Hor ChenRuey-Feng Chang
Dec 23, 2015·Translational Oncology·Jeon-Hor ChenMin-Ying Su
Mar 5, 2011·Academic Radiology·John J HeineDana E Rollison
Jul 28, 2009·Magnetic Resonance Imaging·Catherine KlifaNola Hylton
Oct 14, 2008·Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society·Xiangrong ZhouHiroaki Hoshi
Dec 4, 2015·Medical Physics·Kwan-Hoong Ng, Susie Lau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.